TRANSVAC2 is the follow-up project to its successful predecessor project TRANSVAC, the European Network of Vaccine Research and Development funded under FP7. The TRANSVAC2 consortium comprises a comprehensive collection of leading European institutions that propose to further advance with the previous initiative towards the establishment of a fully operational and sustainable European vaccine R&D infrastructure. TRANSVAC2 will support innovation for both prophylactic and therapeutic vaccine development based on a disease-overarching and one-health approach, thereby optimising the knowledge and expertise gained during the development of both human and animal vaccines. This will be achieved by bridging the translational gap in biomedical research, and by supporting cooperation between public vaccine R&D institutions of excellence, related initiatives and networks in Europe, and industrial partners. TRANSVAC2 will complement and integrate with existing European research infrastructures in both the public and private sectors. TRANSVAC2 will function as leverage and innovation catalyst between all stakeholders involved in vaccine R&D in Europe and -by providing integrated and overarching vaccine R&D services- will contribute to the development of effective products to address European and global health challenges, to controlling the burden and spread of infectious diseases, and reinforce the economic assets represented by vaccine developers in Europe. The impact of TRANSVAC2 will be maximised by two external advisory bodies. An independent Scientific & Ethics Advisory Committee will provide recommendations surrounding scientific-technical and ethical issues, whereas the coordination of TRANSVAC2 with other related initiatives and the further promotion of the long-term stability of a European vaccine R&D infrastructure will be supported by a Board of Stakeholders comprising representatives of policy and decision makers, industry associations and European infrastructures.

Adolescent young carers (AYCs) are young people (15-17 years old) providing significant or substantial care, assistance or support to other family members. The phenomenon is highly relevant across Europe, albeit specific data, awareness and supports are not frequently available. Taking on a caring role constitutes a relevant risk factor for the occurrence of both immediate and long-term problems in AYCs’ mental health, well-being and development, as well as for their transitions to adulthood, social inclusion, education and employability. The goal of the project is to strengthen the resilience of AYCs, improve their mental health and well-being, and mitigate the negative influences of psychosocial and environmental factors. The project develops an innovative framework of primary prevention interventions to be tested and adapted in six European countries (Italy, Netherlands, Slovenia, Sweden, Switzerland, United Kingdom) at different stages of awareness and development of services for AYCs. The project has three specific objectives: (1) to systematise knowledge on AYCs; (2) to co-design, test and deliver psychosocial interventions in six countries; (3) to evaluate what works and provide knowledge translation actions at national, European and international levels. The project adopts an interdisciplinary approach by complementing expertise and longstanding experience of partners. The consortium includes Eurocarers members, research and carers organisations, working together with and for AYCs. AYCs will be continuously involved in the project – together with other stakeholders – via national Blended Learning Networks, user groups, workshops, and in an International Advisory and Ethics Board. The project will have international impact, improving AYCs’ mental health and well-being, educational outcomes, transition, employability and social inclusion, as well as creating evidence-based practices, to improve health equity and societal benefits.